-
Mashup Score: 8The association of neighborhood-level deprivation with glioblastoma outcomes: a single center cohort study - 3 day(s) ago
Journal of Neuro-Oncology – Glioblastoma is the most common primary brain malignancy. Though literature has suggested the association of glioblastoma outcomes and socioeconomic status, there is…
Source: link.springer.comCategories: General Medicine NewsTweet
-
Mashup Score: 11Journal of Neuro-Oncology - 4 day(s) ago
The Journal of Neuro-Oncology (JNO) is a multidisciplinary journal encompassing basic, translational, and clinical investigations in all research areas as …
Source: link.springer.comCategories: General Medicine NewsTweet-
Our newest issue is now available! #JNO Read more at: https://t.co/Rx0ucUBesp https://t.co/TT8m7U0S0K
-
-
Mashup Score: 15
Journal of Neuro-Oncology – Tumor Treating Fields therapy (TTFields) is an FDA-approved locoregional treatment for patients with newly diagnosed glioblastoma (ndGBM). Previous trial data showed the…
Source: link.springer.comCategories: General Medicine NewsTweet-
Riegel et al. @BrittaBureauMD @MedicalCollege analyzed real-world outcomes for newly diagnosed GBM patients treated with or without TTFields and found that TTFields improved OS and PFS, with higher device usage linked to better outcomes. #JNO Read more:https://t.co/iUf2E2o5bH https://t.co/xVq3HsGkwU
-
-
Mashup Score: 9
Journal of Neuro-Oncology – Stereotactic radiosurgery (SRS) has become a standard of care for small- to medium- size vestibular schwannomas (VS), while the majority of patients with large VS still…
Source: link.springer.comCategories: General Medicine NewsTweet-
Tuleasca et al @ctuleasc @jasonpsheehan @ISRSy performed a meta-analysis on large vestibular schwannomas treated w/ planned subtotal resection followed by SRS and found high tumor control and excellent facial and cochlear nerve preservation.#JNO Read more:https://t.co/Kb4dfRfQuu https://t.co/Fqi81mKgXO
-
-
Mashup Score: 14Combined peritumoral radiomics and clinical features predict 12-month progression free survival in glioblastoma - 9 day(s) ago
Journal of Neuro-Oncology – Analyzing post-treatment MRIs from glioblastoma patients can be challenging due to similar radiological presentations of disease progression and treatment effects….
Source: link.springer.comCategories: General Medicine NewsTweet-
Yun et al. @DOncologie showed that combining clinical features with peritumoral radiomics from post-treatment MRIs significantly improved prediction of 12-month PFS in glioblastoma (AUC = 0.75). #JNO Read more:https://t.co/VDaj7CKoB8
-
-
Mashup Score: 17Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience - 17 day(s) ago
Journal of Neuro-Oncology – Bevacizumab is an anti-angiogenetic treatment that can be used in patients with recurrent glioblastoma, but there are limited and controversial data on the optimal dose…
Source: link.springer.comCategories: General Medicine NewsTweet-
Cerretti et al. @DrLombardiGiu analyzed bevacizumab dosing in recurrent glioblastoma and found no significant survival or toxicity difference between high and low doses. The findings favor cost-effective lower-dose regimens. #JNO Read more:https://t.co/eJJqekaM0U https://t.co/tqVcLyQazU
-
-
Mashup Score: 0Comparative analysis of pyrosequencing and next-generation sequencing for assessing MGMT methylation in glioma patients - 20 day(s) ago
Journal of Neuro-Oncology – The methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter is pivotal in clinical decision-making for glioma patients. Pyrosequencing…
Source: link.springer.comCategories: General Medicine NewsTweet-
Shen et al. compared PSQ and NGS for MGMT methylation analysis in glioma and found NGS to be more accurate, efficient, and cost-effective. The results support NGS as a strong alternative to current gold-standard methods. #JNO Read more:https://t.co/st1TdNIgje
-
-
Mashup Score: 16
Journal of Neuro-Oncology – To evaluate short and long-term efficacy of bevacizumab (Bev), for the treatment of radiation necrosis (RN) in patients with brain metastasis after stereotactic…
Source: link.springer.comCategories: General Medicine NewsTweet-
Nobel et al. assessed bevacizumab for radiation necrosis post-SRS, showing strong early response and lesion shrinkage. Yet frequent regrowth and limited re-challenge efficacy reflect the challenges of managing RN. #JNO Read more:https://t.co/Gx2vpTF3Xw
-
-
Mashup Score: 8
Journal of Neuro-Oncology – Alternating electric fields (AEF) therapy in addition to temozolomide chemoradiotherapy (TMZ CRT) is increasingly being recommended as first-line treatment for patients…
Source: link.springer.comCategories: General Medicine NewsTweet-
Woo et al. provided real-world validation for AEF therapy in newly diagnosed grade 4 astrocytoma, demonstrating a meaningful survival benefit when combined with TMZ CRT. High compliance further improved outcomes. #JNO Read more:https://t.co/rL2GqK5vI1 https://t.co/OpZfUxTqX1
-
-
Mashup Score: 5
Journal of Neuro-Oncology – To survey the real-world effectiveness and cost of optic nerve sheath meningioma (ONSM) treating with Gamma Knife Radiosurgery (GKRS), and compare with the external beam…
Source: link.springer.comCategories: General Medicine NewsTweet-
Ma et al. compared GKRS and EBRT for optic nerve sheath meningiomas, finding similar efficacy and safety. GKRS, however, offered a cost advantage and was often favored in shared decision-making. #JNO Read more:https://t.co/7a9ZJuKZDt https://t.co/nyq3mMv2T3
-
Sun et al. @yuff33 @NeurosurgeryUab @dagoestevezMD evaluated the impact of neighborhood-level deprivation on glioblastoma outcomes and found that higher socioeconomic disadvantage was associated with worse overall survival.#JNO Read more:https://t.co/DrrPTueycp https://t.co/FIRhvE4QkS